-
A650725-10mg(Rac)-AZD 6482 ((Rac)-KIN-193) is the racemate of AZD 6482. AZD 6482 is a potent and selective p110β inhibitor with an IC 50 of 0.69 nM.Form:Solid.
-
A650725-50mg(Rac)-AZD 6482 ((Rac)-KIN-193) is the racemate of AZD 6482. AZD 6482 is a potent and selective p110β inhibitor with an IC 50 of 0.69 nM.Form:Solid.
-
A650725-5mg(Rac)-AZD 6482 ((Rac)-KIN-193) is the racemate of AZD 6482. AZD 6482 is a potent and selective p110β inhibitor with an IC 50 of 0.69 nM.Form:Solid.
-
A656388-1ml(Rac)-AZD 6482 ((Rac)-KIN-193) is the racemate of AZD 6482. AZD 6482 is a potent and selective p110β inhibitor with an IC 50 of 0.69 nM.
-
B651922-100mg(Rac)-BAY1238097 is a BET inhibitor, with an IC 50 of 1.02 μM for BRD4 . Used in cancer researchForm:SolidIC50&: Target:IC50: 1.02 μM (BRD4).
-
B651922-10mg(Rac)-BAY1238097 is a BET inhibitor, with an IC 50 of 1.02 μM for BRD4 . Used in cancer researchForm:SolidIC50&: Target:IC50: 1.02 μM (BRD4).
-
B651922-50mg(Rac)-BAY1238097 is a BET inhibitor, with an IC 50 of 1.02 μM for BRD4 . Used in cancer researchForm:SolidIC50&: Target:IC50: 1.02 μM (BRD4).
-
B651922-5mg(Rac)-BAY1238097 is a BET inhibitor, with an IC 50 of 1.02 μM for BRD4 . Used in cancer researchForm:SolidIC50&: Target:IC50: 1.02 μM (BRD4).
-
B656874-1ml(Rac)-BAY1238097 is a BET inhibitor, with an IC 50 of 1.02 μM for BRD4 . Used in cancer researchIC50&: Target:IC50: 1.02 μM (BRD4).
-
B651417-10mg(Rac)-BIO8898 is a CD40-CD154 co-stimulatory interaction inhibitor. (Rac)-BIO8898 inhibits CD154 binding to CD40-Ig with an IC 50 of 25 μM.Form:Solid.
-
B651417-1mg(Rac)-BIO8898 is a CD40-CD154 co-stimulatory interaction inhibitor. (Rac)-BIO8898 inhibits CD154 binding to CD40-Ig with an IC 50 of 25 μM.Form:Solid.
-
B651417-5mg(Rac)-BIO8898 is a CD40-CD154 co-stimulatory interaction inhibitor. (Rac)-BIO8898 inhibits CD154 binding to CD40-Ig with an IC 50 of 25 μM.Form:Solid.